Literature DB >> 1489422

Renal protective effect of enalapril in diabetic nephropathy.

W W Yeo, L E Ramsay, P R Jackson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489422      PMCID: PMC1881682          DOI: 10.1136/bmj.304.6830.841-a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Angiotensin converting enzyme inhibitors and diabetic nephropathy.

Authors:  C E Mogensen
Journal:  BMJ       Date:  1992-02-08

2.  Renal protective effect of enalapril in diabetic nephropathy.

Authors:  S Björck; H Mulec; S A Johnsen; G Nordén; M Aurell
Journal:  BMJ       Date:  1992-02-08

3.  Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease.

Authors:  A J Apperloo; D de Zeeuw; H E Sluiter; P E de Jong
Journal:  BMJ       Date:  1991-10-05

4.  Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure.

Authors:  P S Williams; G Fass; J M Bone
Journal:  Q J Med       Date:  1988-04

Review 5.  Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Authors:  R Collins; R Peto; S MacMahon; P Hebert; N H Fiebach; K A Eberlein; J Godwin; N Qizilbash; J O Taylor; C H Hennekens
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

  5 in total
  2 in total

1.  Specific MAPK inhibitors prevent hyperglycemia-induced renal diseases in type 1 diabetic mouse model.

Authors:  Zhe Hong; Zongyuan Hong; Denglong Wu; Hezhongrong Nie
Journal:  Mol Cell Biochem       Date:  2016-07-07       Impact factor: 3.396

2.  Efficacy of pentoxifylline for reduction of proteinuria in type II diabetic patients.

Authors:  Farshid Oliaei; Shirin Hushmand; Soraya Khafri; Mahmoud Baradaran
Journal:  Caspian J Intern Med       Date:  2011
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.